View in EDS

Prognostic factors for patients treated with abiraterone.

Saved in:
Bibliographic Details
Title: Prognostic factors for patients treated with abiraterone.
Authors: Alvim CM; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal., Mansinho A; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal.; Luís Costa Lab, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, Portugal., Paiva RS; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal., Brás R; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal., Semedo PM; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal., Lobo-Martins S; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal., da Ponte CB; Urology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal., Macedo D; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal., Ribeiro L; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal., Dos Reis JP; Urology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal., Fernandes I; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal.; Luís Costa Lab, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, Portugal., Costa L; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal.; Luís Costa Lab, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, Portugal.
Source: Future science OA [Future Sci OA] 2019 Dec 12; Vol. 6 (2), pp. FSO436. Date of Electronic Publication: 2019 Dec 12.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101665030 Publication Model: Electronic Cited Medium: Print ISSN: 2056-5623 (Print) Linking ISSN: 20565623 NLM ISO Abbreviation: Future Sci OA Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2056-5623
DOI:10.2144/fsoa-2019-0079